175 related articles for article (PubMed ID: 19540557)
1. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases.
Alameda F; Espinet B; Corzo C; Muñoz R; Bellosillo B; Lloveras B; Pijuan L; Gimeno J; Salido M; Solé F; Carreras R; Serrano S
Hum Pathol; 2009 Oct; 40(10):1474-8. PubMed ID: 19540557
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of human telomerase RNA gene (hTERC) amplification in cervical squamous cell lesions detected by fluorescence in situ hybridization.
Jin Y; Li JP; He D; Tang LY; Zee CS; Guo SZ; Zhou J; Chen JN; Shao CK
Asian Pac J Cancer Prev; 2011; 12(5):1167-71. PubMed ID: 21875260
[TBL] [Abstract][Full Text] [Related]
3. Application of hTERC in thinprep samples with mild cytologic abnormality and HR-HPV positive.
Li Y; Zeng WJ; Ye F; Wang XY; Lü WG; Ma D; Wei LH; Xie X
Gynecol Oncol; 2011 Jan; 120(1):73-83. PubMed ID: 21035173
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of genomic amplification of the human telomerase RNA component gene in the screening of cervical lesions].
Jiang J; Tu Z; Zhang G; Li JR; Zhao LJ; Zhao C; Cui SH; Li XP; Chen Z; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2008 Nov; 43(11):849-53. PubMed ID: 19087570
[TBL] [Abstract][Full Text] [Related]
5. Gain of the 3q26 region in cervicovaginal liquid-based pap preparations is associated with squamous intraepithelial lesions and squamous cell carcinoma.
Caraway NP; Khanna A; Dawlett M; Guo M; Guo N; Lin E; Katz RL
Gynecol Oncol; 2008 Jul; 110(1):37-42. PubMed ID: 18433848
[TBL] [Abstract][Full Text] [Related]
6. [Detection of human telomerase RNA component gene by fluorescent in situ hybridization for screening of cervical lesions].
Gao L; Zhu Y; Liu SP; Gao Y; Zhu MH
Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):104-7. PubMed ID: 21426806
[TBL] [Abstract][Full Text] [Related]
7. Role of chromosome 3q26 gain in predicting progression of cervical dysplasia.
Rodolakis A; Biliatis I; Symiakaki H; Kershnar E; Kilpatrick MW; Haidopoulos D; Thomakos N; Antsaklis A
Int J Gynecol Cancer; 2012 Jun; 22(5):742-7. PubMed ID: 22635026
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of hTERC gene detection in exfoliated cervical epithelial cells for cervical lesions.
Zheng X; Liang P; Zheng Y; Yi P; Liu Q; Han J; Huang Y; Zhou Y; Guo J; Li L
Int J Gynecol Cancer; 2013 Jun; 23(5):785-90. PubMed ID: 23669440
[TBL] [Abstract][Full Text] [Related]
9. Detection of human telomerase RNA gene in cervical cancer and precancerous lesions: comparison with cytological and human papillomavirus DNA test findings.
Li Y; Ye F; Lü WG; Zeng WJ; Wei LH; Xie X
Int J Gynecol Cancer; 2010 May; 20(4):631-7. PubMed ID: 20686384
[TBL] [Abstract][Full Text] [Related]
10. Amplification of the 3q chromosomal region as a specific marker in cervical cancer.
Wright TC; Compagno J; Romano P; Grazioli V; Verma Y; Kershnar E; Tafas T; Kilpatrick MW
Am J Obstet Gynecol; 2015 Jul; 213(1):51.e1-51.e8. PubMed ID: 25659466
[TBL] [Abstract][Full Text] [Related]
11. Prediction of outcome in patients with low-grade squamous intraepithelial lesions by fluorescence in situ hybridization analysis of human papillomavirus, TERC, and MYC.
Obermann EC; Savic Prince S; Barascud A; Grilli B; Herzog M; Kaup D; Cathomas G; Frey Tirri B; Zlobec I; Wight E; Bubendorf L
Cancer Cytopathol; 2013 Aug; 121(8):423-31. PubMed ID: 23408758
[TBL] [Abstract][Full Text] [Related]
12. Genomic amplification of the human telomerase gene (hTERC) associated with human papillomavirus is related to the progression of uterine cervical dysplasia to invasive cancer.
Liu H; Liu S; Wang H; Xie X; Chen X; Zhang X; Zhang Y
Diagn Pathol; 2012 Oct; 7():147. PubMed ID: 23107094
[TBL] [Abstract][Full Text] [Related]
13. Clinical Role of the Detection of Human Telomerase RNA Component Gene Amplification by Fluorescence in situ Hybridization on Liquid-Based Cervical Samples: Comparison with Human Papillomavirus-DNA Testing and Histopathology.
Zappacosta R; Ianieri MM; Buca D; Repetti E; Ricciardulli A; Liberati M
Acta Cytol; 2015; 59(4):345-54. PubMed ID: 26343271
[TBL] [Abstract][Full Text] [Related]
14. The detection of hTERC amplification using fluorescence in situ hybridization in the diagnosis and prognosis of cervical intraepithelial neoplasia: a case control study.
Yin G; Li J; Zhu T; Zhao X
World J Surg Oncol; 2012 Aug; 10():168. PubMed ID: 22909227
[TBL] [Abstract][Full Text] [Related]
15. Different amplification patterns of the human telomerase RNA gene in invasive cervical carcinomas and cervical intraepithelial neoplasia grade III.
Xiang L; Yang H; Li J; Wu X; Zhou X
Diagn Cytopathol; 2012 Oct; 40(10):849-55. PubMed ID: 21381227
[TBL] [Abstract][Full Text] [Related]
16. Amplification of the human telomerase gene in liquid-based preparations is associated with cervical dysplasia and carcinoma.
Fan YB; Wu X; Fu ZM; Wu GP
Int J Gynecol Pathol; 2010 Mar; 29(2):157-64. PubMed ID: 20173501
[TBL] [Abstract][Full Text] [Related]
17. Gain of the human telomerase RNA gene TERC at 3q26 is strongly associated with cervical intraepithelial neoplasia and carcinoma.
Sui W; Ou M; Dai Y; Chen J; Lan H; Yan Q; Huang H
Int J Gynecol Cancer; 2009 Nov; 19(8):1303-6. PubMed ID: 20009881
[TBL] [Abstract][Full Text] [Related]
18. Gain of human telomerase RNA gene is associated with progression of cervical intraepithelial neoplasia grade I or II.
Lan YL; Yu L; Jia CW; Wu YM; Wang SY
Chin Med J (Engl); 2012 May; 125(9):1599-602. PubMed ID: 22800828
[TBL] [Abstract][Full Text] [Related]
19. Amplification of 3q26 and 5p15 regions in cervical intraepithelial neoplasia.
Kudela E; Farkasova A; Visnovsky J; Balharek T; Sumichrastova P; Sivakova J; Plank L; Danko J
Acta Obstet Gynecol Scand; 2014 Oct; 93(10):997-1002. PubMed ID: 25174982
[TBL] [Abstract][Full Text] [Related]
20. Human telomerase RNA component (hTERC) gene expression and chromosome 7 ploidy correlate positively with histological grade of cervical intraepithelial neoplasia.
Aggarwal D; Wadhwa N; Arora T; Rajaram S; Diwaker P; Halder A; Jain M; Mishra K
Cytopathology; 2021 Sep; 32(5):631-639. PubMed ID: 33848025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
